Pulmonary hypertension: Difference between revisions
Jump to navigation
Jump to search
imported>Meg Taylor (subpages) |
imported>Robert Badgett (Started treatment section) |
||
| Line 4: | Line 4: | ||
==Diagnosis== | ==Diagnosis== | ||
The [[echocardiogram]] may be more than 10 mm/Hg in error in half of cases.<ref name="pmid19164700">{{cite journal |author=Fisher MR, Forfia PR, Chamera E, ''et al'' |title=Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension |journal=Am. J. Respir. Crit. Care Med. |volume=179 |issue=7 |pages=615–21 |year=2009 |month=April |pmid=19164700 |doi=10.1164/rccm.200811-1691OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=19164700 |issn=}}</ref> | The [[echocardiogram]] may be more than 10 mm/Hg in error in half of cases.<ref name="pmid19164700">{{cite journal |author=Fisher MR, Forfia PR, Chamera E, ''et al'' |title=Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension |journal=Am. J. Respir. Crit. Care Med. |volume=179 |issue=7 |pages=615–21 |year=2009 |month=April |pmid=19164700 |doi=10.1164/rccm.200811-1691OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=19164700 |issn=}}</ref> | ||
==Treatment== | |||
For all patients, consider: | |||
* Inhibitors of [[phosphodiesterase]] type 5 (PDE-5), such as [[sildenafil]]. | |||
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider: | |||
* [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | |||
* [[Endothelin]] receptor antagonists such as [[bosentan]]. | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 10:45, 19 March 2010
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
In medicine, pulmonary hypertension is "increased vascular resistance in the pulmonary circulation, usually secondary to heart diseases or lung diseases."[1]
Diagnosis
The echocardiogram may be more than 10 mm/Hg in error in half of cases.[2]
Treatment
For all patients, consider:
- Inhibitors of phosphodiesterase type 5 (PDE-5), such as sildenafil.
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider:
- Prostaglandins, such as iloprost, treprostinil, or epoprostenol.
- Endothelin receptor antagonists such as bosentan.
References
- ↑ Anonymous (2024), Pulmonary hypertension (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Fisher MR, Forfia PR, Chamera E, et al (April 2009). "Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension". Am. J. Respir. Crit. Care Med. 179 (7): 615–21. DOI:10.1164/rccm.200811-1691OC. PMID 19164700. Research Blogging.